Clinical utility in maximizing CD34+ cell count in stem cell grafts

Oncologist

Volumn 4, Issue 3, 1999, Pages 265-268

  Burt, Richard K ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ALLOGRAFT; AUTOTRANSPLANTATION; BLOOD CELL COUNT; CELL SUBPOPULATION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0032992457     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.4-3-265     Document Type: Review

References (22)

1. Weaver CH, Hazelton B, Birch R et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995;86:3961-3969.
2. Kiss JE, Rybka WB, Winkelsein A et al. Relationship of CD34 cell dose to early and late hematopoiesis following autologous peripheral-blood stem-cell transplantation. Bone Marrow Transplant 1997;19:303-310.
3. + cells and rapid hematopoietic recovery after peripheral blood stem cell transplantation. J Clin Oncol 1995;13:1922-1932.
4. Burt RK, Kuzel TM, Fishman M et al. Stem cell component therapy: supplementation of unmanipulated marrow with CD34 enriched peripheral blood stem cells. Bone Marrow Transplant 1999;23:381-386.
5. Aversa F, Tabilio A, Velardi A et al. Treatment of high-risk leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 1998;339:1186-1193.
6. Storek J, Gooley T, Siadak M et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood 1997;90:4705-4709.
7. Majolino I, Saglio G, Scime R et al. High incidence of chronic GVHD after primary allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies. Bone Marrow Transplant 1996;17:555-560.
8. Urbano-Ispizua A, Garcia-Conde S, Brunet S et al. High incidence of chronic GVHD after allogeneic peripheral blood progenitor cell transplantation from related donors. Blood 1996;88:617a.
9. Korbling M, Mirza N, Thall P et al. 100 HLA-identical allogeneic blood stem cell transplantations: the M.D. Anderson Cancer Center experience. Bone Marrow Transplant 1997;19:S72a.
10. Schmitz N, Dreger P, Suttorp M et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995;85:1666-1672.
11. Korbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995;85:1659-1665.
12. Bensinger WI, Weaver CH, Appelbaum FR et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995;85:1655-1658.
13. Brown RA, Adkins D, Goodnough M et al. Allogeneic peripheral blood progenitor cell transplant does not appear to increase the risk of acute GVHD following HLA identical sibling transplant. Blood 1995;86:393a.
14. Urbano-Ispizua A, Solano C, Brunet S et al. Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. Bone Marrow Transplant 1996;18:35-40.
15. Schmitz N, Bacigalupo A, Hasenclever D et al. Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1998;21:995-1003.
16. Zeng D, Dejbakhsh-Jones S, Stober S. Granulocyte colony-stimulating factor reduces the capacity of blood mononuclear cells to induce graft-versus-host disease: impact on blood progenitor cell transplantation. Blood 1997;90:453-463.
17. Bensinger WI, Clift R, Martin P et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood 1996;88:2794-2800.
18. Russell JA, Brown C, Bowen T et al. Allogeneic blood cell transplants for haematological malignancy: preliminary comparison of outcomes with bone marrow transplantation. Bone Marrow Transplant 1996;17:703-708.
19. + cell content but is associated with delayed pancytopenia. Bone Marrow Transplant 1998;21:431-440.
20. Bachar-Lustig E, Rachmim N, Li HW et al. Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice. Nat Med 1995;1:1268-1273.
21. Rachamim N, Gan J, Segall H et al. Potential role of CD34 stem cells in tolerance induction. Transplant Proc 1997;29:1935-1936.
22. + hematopoietic cells. Blood 1996;88:2619-2625.